1. Home
  2. BCRX vs TRIN Comparison

BCRX vs TRIN Comparison

Compare BCRX & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$7.20

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Logo Trinity Capital Inc.

TRIN

Trinity Capital Inc.

N/A

Current Price

$16.71

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BCRX
TRIN
Founded
1986
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
BCRX
TRIN
Price
$7.20
$16.71
Analyst Decision
Buy
Buy
Analyst Count
11
9
Target Price
★ $20.45
$19.00
AVG Volume (30 Days)
★ 4.5M
838.8K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
★ 12.06%
EPS Growth
★ 381.40
N/A
EPS
N/A
★ 1.35
Revenue
★ $25,186,000.00
N/A
Revenue This Year
N/A
$34.35
Revenue Next Year
$3.71
$16.34
P/E Ratio
★ N/A
$12.53
Revenue Growth
N/A
★ N/A
52 Week Low
$6.23
$14.13
52 Week High
$11.22
$18.90

Technical Indicators

Market Signals
Indicator
BCRX
TRIN
Relative Strength Index (RSI) 35.29 37.23
Support Level N/A $15.64
Resistance Level $8.83 $17.35
Average True Range (ATR) 0.37 0.37
MACD -0.05 -0.10
Stochastic Oscillator 0.87 0.08

Price Performance

Historical Comparison
BCRX
TRIN

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About TRIN Trinity Capital Inc.

Trinity Capital Inc is an internally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, capital appreciation through investments across five distinct vertical markets. The company is focused on achieving its investment objective by operating as a specialty lending company that provides debt, including loans, equipment financings, and asset-based lending, to growth-oriented companies, including institutional investor-backed companies. Its investment portfolio mainly comprises private companies that have begun to have success selling their products to the market and need additional capital to expand their operations and sales.

Share on Social Networks: